Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
 
Advanced search:
Enter Search Keyword
 
Filter your search by:
Industry
Country
Publish date
Search By Price Range
From:$
    To:$
 
MP ADVISORS
Results 1-10 of 11  1 2 >  Sort By :
Title Date Price
Therapeutic Class Overview : New Avatars Of Microbes Super Bugs A Growing Threat Worldwide
By MP ADVISORS
Novel approaches to treat infection is growing as the need is urgent! Misuse/overuse of antibiotics accelerated antimicrobial resistance (AMR) and has resulted in the emergence of “super bugs&rd ...Read More
Feb 2014 $1500.00
Therapeutic Class Overview: Newer Oral Anti Androgens - Expanding Role in the treatment Paradigm of Prostate Cancer
By MP ADVISORS
In recent past approval and launch of various newer treatment options like Xtandi (Enzalutamide, Astellas/Medivation), Zytiga (Abiraterone acetate, JNJ), Jevtana (Cabazitaxel, Sanofi), & Xofigo (r ...Read More
Feb 2014 $2500.00
Therapeutic Class Overview : Emergence Of Biogenerics Era In Japan - It's Time to Welcome Antibody Biosimilars of Foreign Origins Soon
By MP ADVISORS
With three products and eight players already in market – Japan biosimilar market will enter new phase of biosimilars with first ‘mab’ approval expected in 2014.  This approval ...Read More
Feb 2014 $2500.00
Therapeutic Class Overview: Treating Refractory Hematological Malignancies
By MP ADVISORS
Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes.  Over the past decade, Proteasome in ...Read More
Feb 2014 $2500.00
Innovative Drug Delivery Systems Opportunities for Generic & Specialty Pharmaceutical companies
By MP ADVISORS
There are more than 1400 sustained or controlled release drugs have been approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a ...Read More
Feb 2014 $2500.00
Therapeutic Class Overview : Psoriasis -Plaque Psoriasis & Psoriatic Arthritis : Novel Oral drugs and Biologics to Change Future Treatment Paradigm
By MP ADVISORS
Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded considerably and improved patients’ pain, function, and quality of life.  A ...Read More
Feb 2014 $2500.00
Global Pharmaceutical & Biotechnology Outlook 2014: Mature Biotech
By MP ADVISORS
Positive sentiments for the biotech sector have prevailed in the last two to three years, and we expect this trend to continue for the next year too.  Our optimism is based on the continuity in t ...Read More
Jan 2014 $2500.00
Global Pharmaceutical & Biotechnology Outlook 2014: Major US and EU
By MP ADVISORS
Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition In the recent years se ...Read More
Jan 2014 $2500.00
Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma
By MP ADVISORS
2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations.  We find these re ...Read More
Jan 2014 $2500.00
Global Pharmaceutical and Biotechnology Outlook 2014 - India Pharma
By MP ADVISORS
Indian companies are taking center stage in Complex Generics at US and EU markets.  In Bio-similars, Indian companies will have perhaps the largest basket aimed at Emerging Countries in 2014-16 a ...Read More
Jan 2014 $2500.00
Results 1-10 of 11  1 2 > 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z